0001104659-23-129255.txt : 20231226 0001104659-23-129255.hdr.sgml : 20231226 20231226170807 ACCESSION NUMBER: 0001104659-23-129255 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231221 FILED AS OF DATE: 20231226 DATE AS OF CHANGE: 20231226 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bernstein Bruce CENTRAL INDEX KEY: 0001665472 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39752 FILM NUMBER: 231513945 MAIL ADDRESS: STREET 1: 780 THIRD AVENUE, 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Petros Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001815903 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 851410058 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1185 AVENUE OF THE AMERICAS, 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 BUSINESS PHONE: 973-242-0005 MAIL ADDRESS: STREET 1: 1185 AVENUE OF THE AMERICAS, 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 4 1 tm2333705-3_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2023-12-21 0 0001815903 Petros Pharmaceuticals, Inc. PTPI 0001665472 Bernstein Bruce C/O PETROS PHARMACEUTICALS, INC. 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 1 0 0 0 0 Stock Option (Right to Buy) 1.41 2023-12-21 4 A 0 40000 0 A 2033-12-21 Common Stock 40000 40000 D The stock options will vest on April 10, 2024, provided that the Reporting Person has continued to provide services to Petros Pharmaceuticals, Inc. through the vesting date. /s/ Mitchell Arnold, attorney-in-fact 2023-12-26